Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Japan flag Japan · Delayed Price · Currency is JPY
3,690.00
-50.00 (-1.34%)
At close: Mar 6, 2026
12.16%
Market Cap 130.81B
Revenue (ttm) 111.92B
Net Income (ttm) 6.42B
Shares Out 35.45M
EPS (ttm) 181.15
PE Ratio 20.37
Forward PE n/a
Dividend 80.00 (2.17%)
Ex-Dividend Date Mar 30, 2026
Volume 23,700
Average Volume 42,270
Open 3,685.00
Previous Close 3,740.00
Day's Range 3,660.00 - 3,715.00
52-Week Range 2,836.00 - 3,965.00
Beta -0.07
RSI 46.01
Earnings Date May 12, 2026

About Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and p... [Read more]

Sector Healthcare
Founded 1913
Employees 1,508
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4534
Full Company Profile

Financial Performance

In fiscal year 2025, Mochida Pharmaceutical's revenue was 105.16 billion, an increase of 2.21% compared to the previous year's 102.89 billion. Earnings were 5.69 billion, an increase of 25.03%.

Financial Statements

News

There is no news available yet.